Share on StockTwits

BioDelivery Sciences International (NASDAQ:BDSI) Director Francis E. Odonnell, Jr. sold 125,000 shares of BioDelivery Sciences International stock on the open market in a transaction dated Wednesday, June 11th. The shares were sold at an average price of $11.04, for a total value of $1,380,000.00. The sale was disclosed in a legal filing with the SEC, which is available at this link.

BDSI has been the subject of a number of recent research reports. Analysts at Ladenburg Thalmann raised their price target on shares of BioDelivery Sciences International to $18.00 in a research note on Monday. They now have a “buy” rating on the stock. Separately, analysts at Roth Capital raised their price target on shares of BioDelivery Sciences International to $15.50 in a research note on Monday. They now have a “buy” rating on the stock. Finally, analysts at Laidlaw reiterated a “buy” rating on shares of BioDelivery Sciences International in a research note on Monday. They now have a $15.00 price target on the stock. One research analyst has rated the stock with a sell rating and five have given a buy rating to the company. The stock currently has an average rating of “Buy” and an average target price of $19.25.

Shares of BioDelivery Sciences International (NASDAQ:BDSI) traded up 0.57% during mid-day trading on Friday, hitting $12.36. The stock had a trading volume of 935,153 shares. BioDelivery Sciences International has a one year low of $3.86 and a one year high of $12.56. The stock’s 50-day moving average is $9.28 and its 200-day moving average is $7.84. The company’s market cap is $598.7 million.

BioDelivery Sciences International (NASDAQ:BDSI) last issued its quarterly earnings data on Friday, May 9th. The company reported ($0.11) EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.15) by $0.04. The company had revenue of $20.69 million for the quarter, compared to the consensus estimate of $11.60 million. On average, analysts predict that BioDelivery Sciences International will post $-0.62 earnings per share for the current fiscal year.

BioDelivery Sciences International, Inc (NASDAQ:BDSI) is a specialty pharmaceutical company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.